Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.
-
Upload
jack-fields -
Category
Documents
-
view
236 -
download
0
description
Transcript of Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.
![Page 1: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/1.jpg)
Domonic Zarrini
Zimmer Holdings, Inc. (ZMH)-NYSE 112.09
![Page 2: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/2.jpg)
Screening ProcessFocus on Domestic Stocks
• Industry Classification: • Healthcare Equipment and Services (primary)
• 99601• Exchanges (All Listing):
• Major US Exchanges • 279
• Forward P/E:• Capital IQ (NTM) Greater than 17
• 126• LT EPS Growth Rate:
• Capital IQ (Latest) Greater than 7• 115
• EPS Surprise – Capital IQ (FY)• Greater than 0
• 58
![Page 3: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/3.jpg)
Company Overview• Zimmer Holdings, Inc. designs, develops, manufactures, and
markets orthopaedic and dental reconstructive implants, spinal implants, trauma products and related surgical products. The Company also provides other healthcare related services.
• Ticker: ZMH• Sector: Health Care• Industry: Medical Equipment & Devices• Sub-Industry: Medical Devices• Headquarters: Warsaw, IN• Employees: 8,500• CEO: David Dvorak• Market Cap: 19.02B
![Page 4: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/4.jpg)
Revenue Drivers
• Reconstructive Implants• Competitive advantage lies in hip & knee
reconstructive implants due to acquisition of Centerpulse
• Sell contracts primarily to hospitals, clinics, private practices, orthopedic surgeons
![Page 5: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/5.jpg)
Recent Trends
• Decreased debt by over 3%, bringing it down to just over 20%
• Stryker increased debt from 17.1% to 31.5% in a span of 2 years
• Zimmer is not taking advantage of cheap debt in the market
• Increased use of off-balance sheet financing by way of lease agreements
• Grew long term capital leases by 6%
![Page 6: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/6.jpg)
Sector Overview
![Page 7: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/7.jpg)
S&P 500, Sector, & Subsector Chart
![Page 8: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/8.jpg)
Geographical Distribution and Product Segments
![Page 9: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/9.jpg)
SWOT AnalysisStrengths
Strong manufacturing and commercial capabilities
Extensive portfolio of orthopedic reconstructive implants
WeaknessesWeak presence in emerging Asian
markets may restrict growth
OpportunitiesStrategic acquisitions and joint venturesFavorable demographic trends in the US
likely to boost demand for the company’s medical devices
ThreatsGroup purchasing organizations’ cost
containment measuresInadequate levels of reimbursement
may affect the company’s sale growth
![Page 10: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/10.jpg)
Earnings and PE Growth
![Page 11: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/11.jpg)
Earnings Analysis
![Page 12: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/12.jpg)
Balance Sheet Analysis
![Page 13: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/13.jpg)
Earnings Surprise
![Page 14: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/14.jpg)
EPS Projections
![Page 15: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/15.jpg)
![Page 16: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/16.jpg)
Altman-Z Score
![Page 17: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/17.jpg)
Discounted Cash Flow
![Page 18: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/18.jpg)
EPS Growth
![Page 19: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/19.jpg)
Competitor/Industry Comparison
![Page 20: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/20.jpg)
![Page 21: Domonic Zarrini Zimmer Holdings, Inc. (ZMH)-NYSE 112.09.](https://reader035.fdocuments.us/reader035/viewer/2022081421/5a4d1b607f8b9ab0599ace4e/html5/thumbnails/21.jpg)
Recommendation
Undervalued: BUY